Cargando…
Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015)
BACKGROUND: Retention in care is critical for children living with HIV taking antiretroviral therapy (ART). Loss to follow-up (LTFU) is high in HIV treatment programs in resource limited settings. We estimated the cumulative incidence of LTFU and identified associated risk factors among children on...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694674/ https://www.ncbi.nlm.nih.gov/pubmed/31416432 http://dx.doi.org/10.1186/s12889-019-7374-0 |
_version_ | 1783443876353146880 |
---|---|
author | Mutanga, Jane N. Mutembo, Simon Ezeamama, Amara E. Song, Xiao Fubisha, Robert C. Mutesu-Kapembwa, Kunda Sialondwe, Derrick Simuchembu, Brenda Chinyonga, Jelita Thuma, Philip E. Whalen, Christopher C. |
author_facet | Mutanga, Jane N. Mutembo, Simon Ezeamama, Amara E. Song, Xiao Fubisha, Robert C. Mutesu-Kapembwa, Kunda Sialondwe, Derrick Simuchembu, Brenda Chinyonga, Jelita Thuma, Philip E. Whalen, Christopher C. |
author_sort | Mutanga, Jane N. |
collection | PubMed |
description | BACKGROUND: Retention in care is critical for children living with HIV taking antiretroviral therapy (ART). Loss to follow-up (LTFU) is high in HIV treatment programs in resource limited settings. We estimated the cumulative incidence of LTFU and identified associated risk factors among children on ART at Livingstone Central Hospital (LCH), Zambia. METHODS: Using a retrospective cohort study design, we abstracted data from medical records of children who received ART between 2003 and 2015. Loss to follow-up was defined as no clinical and pharmacy contact for at least 90 days after the child missed their last scheduled clinical visit. Non-parametric competing risks models were used to estimate the cumulative incidence of death, LTFU and transfer. Cause-specific Cox regression was used to estimate the hazard ratios of the risk factors of LTFU. RESULTS: A total of 1039 children aged 0–15 years commenced ART at LCH between 2003 and 2015. Median duration of follow-up was 3.8 years (95% CI: 1.2–6.5), median age at ART initiation was 3.6 years (IQR: 1.3–8.6), 179 (17%) started treatment during their first year of life. At least 167 (16%) were LTFU and we traced 151 (90%). Of those we traced, 39 (26%) had died, 71 (47%) defaulted, 20 (13%) continued ART at other clinics and 21 (14%) continued treatment with gaps. The cumulative incidence of LTFU for the entire cohort was 2.7% (95% CI: 1.9–3.9) at 3 months, 4.1% (95% CI: 2.9–5.4) at 6 months and 14.1% (95% CI: 12.4–16.9) after 5 years on ART. Associated risk factors were: 1) non-disclosure of HIV status at baseline, aHR = 1.9 (1.2–2.9), 2) No phone ownership, aHR = 2.1 (1.6–2.9), 3) starting treatment between 2013 to 2015, aHR = 5.6 (2.2–14.1). CONCLUSION: Among the children LTFU mortality and default were substantially high. Children who started treatment in recent years (2013–2015) had the highest hazard of LTFU. Lack of access to a phone and non-disclosure of HIV-status to the index child was associated with higher hazards of LTFU. We recommend re-enforcement of client counselling and focused follow-up strategies using modern technology such as mobile phones as adjunct to current approaches. |
format | Online Article Text |
id | pubmed-6694674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66946742019-08-19 Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015) Mutanga, Jane N. Mutembo, Simon Ezeamama, Amara E. Song, Xiao Fubisha, Robert C. Mutesu-Kapembwa, Kunda Sialondwe, Derrick Simuchembu, Brenda Chinyonga, Jelita Thuma, Philip E. Whalen, Christopher C. BMC Public Health Research Article BACKGROUND: Retention in care is critical for children living with HIV taking antiretroviral therapy (ART). Loss to follow-up (LTFU) is high in HIV treatment programs in resource limited settings. We estimated the cumulative incidence of LTFU and identified associated risk factors among children on ART at Livingstone Central Hospital (LCH), Zambia. METHODS: Using a retrospective cohort study design, we abstracted data from medical records of children who received ART between 2003 and 2015. Loss to follow-up was defined as no clinical and pharmacy contact for at least 90 days after the child missed their last scheduled clinical visit. Non-parametric competing risks models were used to estimate the cumulative incidence of death, LTFU and transfer. Cause-specific Cox regression was used to estimate the hazard ratios of the risk factors of LTFU. RESULTS: A total of 1039 children aged 0–15 years commenced ART at LCH between 2003 and 2015. Median duration of follow-up was 3.8 years (95% CI: 1.2–6.5), median age at ART initiation was 3.6 years (IQR: 1.3–8.6), 179 (17%) started treatment during their first year of life. At least 167 (16%) were LTFU and we traced 151 (90%). Of those we traced, 39 (26%) had died, 71 (47%) defaulted, 20 (13%) continued ART at other clinics and 21 (14%) continued treatment with gaps. The cumulative incidence of LTFU for the entire cohort was 2.7% (95% CI: 1.9–3.9) at 3 months, 4.1% (95% CI: 2.9–5.4) at 6 months and 14.1% (95% CI: 12.4–16.9) after 5 years on ART. Associated risk factors were: 1) non-disclosure of HIV status at baseline, aHR = 1.9 (1.2–2.9), 2) No phone ownership, aHR = 2.1 (1.6–2.9), 3) starting treatment between 2013 to 2015, aHR = 5.6 (2.2–14.1). CONCLUSION: Among the children LTFU mortality and default were substantially high. Children who started treatment in recent years (2013–2015) had the highest hazard of LTFU. Lack of access to a phone and non-disclosure of HIV-status to the index child was associated with higher hazards of LTFU. We recommend re-enforcement of client counselling and focused follow-up strategies using modern technology such as mobile phones as adjunct to current approaches. BioMed Central 2019-08-15 /pmc/articles/PMC6694674/ /pubmed/31416432 http://dx.doi.org/10.1186/s12889-019-7374-0 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Mutanga, Jane N. Mutembo, Simon Ezeamama, Amara E. Song, Xiao Fubisha, Robert C. Mutesu-Kapembwa, Kunda Sialondwe, Derrick Simuchembu, Brenda Chinyonga, Jelita Thuma, Philip E. Whalen, Christopher C. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015) |
title | Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015) |
title_full | Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015) |
title_fullStr | Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015) |
title_full_unstemmed | Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015) |
title_short | Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003–2015) |
title_sort | predictors of loss to follow-up among children on long-term antiretroviral therapy in zambia (2003–2015) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694674/ https://www.ncbi.nlm.nih.gov/pubmed/31416432 http://dx.doi.org/10.1186/s12889-019-7374-0 |
work_keys_str_mv | AT mutangajanen predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015 AT mutembosimon predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015 AT ezeamamaamarae predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015 AT songxiao predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015 AT fubisharobertc predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015 AT mutesukapembwakunda predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015 AT sialondwederrick predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015 AT simuchembubrenda predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015 AT chinyongajelita predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015 AT thumaphilipe predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015 AT whalenchristopherc predictorsoflosstofollowupamongchildrenonlongtermantiretroviraltherapyinzambia20032015 |